Chelsea Therapeutics International Ltd.
) was a big mover last session, as the company saw its shares
rise by almost 9% on the day. The move came on solid volume too
with far more shares changing hands than in a normal session.
This continues the recent uptrend for the company as the stock is
now up over 28% in the past one-month time frame.
This biotechnology company has seen two positive revisions over
the last 30 days and its Zacks Consensus Estimate moved higher
over the same time frame, suggesting that more solid trading
could be ahead for Chelsea Therapeutics. So make sure to keep an
eye on this stock going forward to see if this recent move higher
can turn into more strength down the road.
Chelsea Therapeutics currently has a Zacks Rank #3 (Hold) while
Some better-ranked stocks in the bio-med industry include
). While Heska Corporation and Actelion hold a Zacks Rank #1
(Strong Buy), Amgen carries a Zacks Rank #2 (Buy).
Want the latest recommendations from Zacks Investment Research?
Today, you can download
7 Best Stocks for the Next 30 Days.
Click to get this free report >>
ACTELION LTD (ALIOF): Get Free Report
AMGEN INC (AMGN): Free Stock Analysis Report
CHELSEA THERAP (CHTP): Free Stock Analysis
HESKA CORP (HSKA): Free Stock Analysis Report
To read this article on Zacks.com click here.